ANN LEEN to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications ANN LEEN has written about Xenograft Model Antitumor Assays.
Connection Strength
0.218
-
Reversal of tumor immune inhibition using a chimeric cytokine receptor. Mol Ther. 2014 Jun; 22(6):1211-1220.
Score: 0.085
-
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. Front Immunol. 2025; 16:1618404.
Score: 0.047
-
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer. 2019 11 28; 7(1):330.
Score: 0.032
-
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov. 2018 08; 8(8):972-987.
Score: 0.029
-
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clin Cancer Res. 2017 Jul 15; 23(14):3499-3509.
Score: 0.026